Furthermore, we confirmed that ARID1A itself is, indeed, mainly localized at enhancers in colorectal cancer cells where it acts as a co-factor at regions bound by AP1 transcription factors, which act downstream of the MEK/ERK pathway. Here, ARID1A is linked to colorectal cancer.